Global Oncology Biosimilars Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Oncology Biosimilars are kind of Biosimilars. A biosimilar product is a biologic agent that is highly similar to an already-approved biological compound, known as the reference or originator product, and approved for use in the same indications as the reference product
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Oncology Biosimilars market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Oncology Biosimilars market are covered in Chapter 9:
Mylan
Celltrion Inc.
Dr. Reddy's Laboratories
Pfizer Inc.
STADA Arzneimittel AG
F Hoffmann-La Roche
BIOCAD
Sandoz International GmbH
Biocon
Apotex Inc.
Teva Pharmaceutical Industries Ltd.
Intas Pharmaceuticals Ltd.
In Chapter 5 and Chapter 7.3, based on types, the Oncology Biosimilars market from 2017 to 2027 is primarily split into:
G-CSF
Hematopoietic Agents
Monoclonal Antibodies
In Chapter 6 and Chapter 7.4, based on applications, the Oncology Biosimilars market from 2017 to 2027 covers:
Retail pharmacies
Hospital pharmacies
Online pharmacies
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Oncology Biosimilars market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Oncology Biosimilars Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 ONCOLOGY BIOSIMILARS MARKET OVERVIEW
1.1 Product Overview and Scope of Oncology Biosimilars Market
1.2 Oncology Biosimilars Market Segment by Type
1.2.1 Global Oncology Biosimilars Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Oncology Biosimilars Market Segment by Application
1.3.1 Oncology Biosimilars Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Oncology Biosimilars Market, Region Wise (2017-2027)
1.4.1 Global Oncology Biosimilars Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.3 Europe Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.4 China Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.5 Japan Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.6 India Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.8 Latin America Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Oncology Biosimilars Market Status and Prospect (2017-2027)
1.5 Global Market Size of Oncology Biosimilars (2017-2027)
1.5.1 Global Oncology Biosimilars Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Oncology Biosimilars Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Oncology Biosimilars Market
2 INDUSTRY OUTLOOK
2.1 Oncology Biosimilars Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Oncology Biosimilars Market Drivers Analysis
2.4 Oncology Biosimilars Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Oncology Biosimilars Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Oncology Biosimilars Industry Development
3 GLOBAL ONCOLOGY BIOSIMILARS MARKET LANDSCAPE BY PLAYER
3.1 Global Oncology Biosimilars Sales Volume and Share by Player (2017-2022)
3.2 Global Oncology Biosimilars Revenue and Market Share by Player (2017-2022)
3.3 Global Oncology Biosimilars Average Price by Player (2017-2022)
3.4 Global Oncology Biosimilars Gross Margin by Player (2017-2022)
3.5 Oncology Biosimilars Market Competitive Situation and Trends
3.5.1 Oncology Biosimilars Market Concentration Rate
3.5.2 Oncology Biosimilars Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ONCOLOGY BIOSIMILARS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Oncology Biosimilars Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Oncology Biosimilars Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Oncology Biosimilars Market Under COVID-19
4.5 Europe Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Oncology Biosimilars Market Under COVID-19
4.6 China Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Oncology Biosimilars Market Under COVID-19
4.7 Japan Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Oncology Biosimilars Market Under COVID-19
4.8 India Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Oncology Biosimilars Market Under COVID-19
4.9 Southeast Asia Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Oncology Biosimilars Market Under COVID-19
4.10 Latin America Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Oncology Biosimilars Market Under COVID-19
4.11 Middle East and Africa Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Oncology Biosimilars Market Under COVID-19
5 GLOBAL ONCOLOGY BIOSIMILARS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Oncology Biosimilars Sales Volume and Market Share by Type (2017-2022)
5.2 Global Oncology Biosimilars Revenue and Market Share by Type (2017-2022)
5.3 Global Oncology Biosimilars Price by Type (2017-2022)
5.4 Global Oncology Biosimilars Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Oncology Biosimilars Sales Volume, Revenue and Growth Rate of G-CSF (2017-2022)
5.4.2 Global Oncology Biosimilars Sales Volume, Revenue and Growth Rate of Hematopoietic Agents (2017-2022)
5.4.3 Global Oncology Biosimilars Sales Volume, Revenue and Growth Rate of Monoclonal Antibodies (2017-2022)
6 GLOBAL ONCOLOGY BIOSIMILARS MARKET ANALYSIS BY APPLICATION
6.1 Global Oncology Biosimilars Consumption and Market Share by Application (2017-2022)
6.2 Global Oncology Biosimilars Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Oncology Biosimilars Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Oncology Biosimilars Consumption and Growth Rate of Retail pharmacies (2017-2022)
6.3.2 Global Oncology Biosimilars Consumption and Growth Rate of Hospital pharmacies (2017-2022)
6.3.3 Global Oncology Biosimilars Consumption and Growth Rate of Online pharmacies (2017-2022)
7 GLOBAL ONCOLOGY BIOSIMILARS MARKET FORECAST (2022-2027)
7.1 Global Oncology Biosimilars Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Oncology Biosimilars Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Oncology Biosimilars Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Oncology Biosimilars Price and Trend Forecast (2022-2027)
7.2 Global Oncology Biosimilars Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Oncology Biosimilars Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Oncology Biosimilars Revenue and Growth Rate of G-CSF (2022-2027)
7.3.2 Global Oncology Biosimilars Revenue and Growth Rate of Hematopoietic Agents (2022-2027)
7.3.3 Global Oncology Biosimilars Revenue and Growth Rate of Monoclonal Antibodies (2022-2027)
7.4 Global Oncology Biosimilars Consumption Forecast by Application (2022-2027)
7.4.1 Global Oncology Biosimilars Consumption Value and Growth Rate of Retail pharmacies(2022-2027)
7.4.2 Global Oncology Biosimilars Consumption Value and Growth Rate of Hospital pharmacies(2022-2027)
7.4.3 Global Oncology Biosimilars Consumption Value and Growth Rate of Online pharmacies(2022-2027)
7.5 Oncology Biosimilars Market Forecast Under COVID-19
8 ONCOLOGY BIOSIMILARS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Oncology Biosimilars Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Oncology Biosimilars Analysis
8.6 Major Downstream Buyers of Oncology Biosimilars Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Oncology Biosimilars Industry
9 PLAYERS PROFILES
9.1 Mylan
9.1.1 Mylan Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Oncology Biosimilars Product Profiles, Application and Specification
9.1.3 Mylan Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Celltrion Inc.
9.2.1 Celltrion Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Oncology Biosimilars Product Profiles, Application and Specification
9.2.3 Celltrion Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Dr. Reddy's Laboratories
9.3.1 Dr. Reddy's Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Oncology Biosimilars Product Profiles, Application and Specification
9.3.3 Dr. Reddy's Laboratories Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Pfizer Inc.
9.4.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Oncology Biosimilars Product Profiles, Application and Specification
9.4.3 Pfizer Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 STADA Arzneimittel AG
9.5.1 STADA Arzneimittel AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Oncology Biosimilars Product Profiles, Application and Specification
9.5.3 STADA Arzneimittel AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 F Hoffmann-La Roche
9.6.1 F Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Oncology Biosimilars Product Profiles, Application and Specification
9.6.3 F Hoffmann-La Roche Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 BIOCAD
9.7.1 BIOCAD Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Oncology Biosimilars Product Profiles, Application and Specification
9.7.3 BIOCAD Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Sandoz International GmbH
9.8.1 Sandoz International GmbH Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Oncology Biosimilars Product Profiles, Application and Specification
9.8.3 Sandoz International GmbH Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Biocon
9.9.1 Biocon Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Oncology Biosimilars Product Profiles, Application and Specification
9.9.3 Biocon Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Apotex Inc.
9.10.1 Apotex Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Oncology Biosimilars Product Profiles, Application and Specification
9.10.3 Apotex Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Teva Pharmaceutical Industries Ltd.
9.11.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Oncology Biosimilars Product Profiles, Application and Specification
9.11.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Intas Pharmaceuticals Ltd.
9.12.1 Intas Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Oncology Biosimilars Product Profiles, Application and Specification
9.12.3 Intas Pharmaceuticals Ltd. Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Oncology Biosimilars Market
1.2 Oncology Biosimilars Market Segment by Type
1.2.1 Global Oncology Biosimilars Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Oncology Biosimilars Market Segment by Application
1.3.1 Oncology Biosimilars Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Oncology Biosimilars Market, Region Wise (2017-2027)
1.4.1 Global Oncology Biosimilars Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.3 Europe Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.4 China Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.5 Japan Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.6 India Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.8 Latin America Oncology Biosimilars Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Oncology Biosimilars Market Status and Prospect (2017-2027)
1.5 Global Market Size of Oncology Biosimilars (2017-2027)
1.5.1 Global Oncology Biosimilars Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Oncology Biosimilars Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Oncology Biosimilars Market
2 INDUSTRY OUTLOOK
2.1 Oncology Biosimilars Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Oncology Biosimilars Market Drivers Analysis
2.4 Oncology Biosimilars Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Oncology Biosimilars Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Oncology Biosimilars Industry Development
3 GLOBAL ONCOLOGY BIOSIMILARS MARKET LANDSCAPE BY PLAYER
3.1 Global Oncology Biosimilars Sales Volume and Share by Player (2017-2022)
3.2 Global Oncology Biosimilars Revenue and Market Share by Player (2017-2022)
3.3 Global Oncology Biosimilars Average Price by Player (2017-2022)
3.4 Global Oncology Biosimilars Gross Margin by Player (2017-2022)
3.5 Oncology Biosimilars Market Competitive Situation and Trends
3.5.1 Oncology Biosimilars Market Concentration Rate
3.5.2 Oncology Biosimilars Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ONCOLOGY BIOSIMILARS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Oncology Biosimilars Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Oncology Biosimilars Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Oncology Biosimilars Market Under COVID-19
4.5 Europe Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Oncology Biosimilars Market Under COVID-19
4.6 China Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Oncology Biosimilars Market Under COVID-19
4.7 Japan Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Oncology Biosimilars Market Under COVID-19
4.8 India Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Oncology Biosimilars Market Under COVID-19
4.9 Southeast Asia Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Oncology Biosimilars Market Under COVID-19
4.10 Latin America Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Oncology Biosimilars Market Under COVID-19
4.11 Middle East and Africa Oncology Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Oncology Biosimilars Market Under COVID-19
5 GLOBAL ONCOLOGY BIOSIMILARS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Oncology Biosimilars Sales Volume and Market Share by Type (2017-2022)
5.2 Global Oncology Biosimilars Revenue and Market Share by Type (2017-2022)
5.3 Global Oncology Biosimilars Price by Type (2017-2022)
5.4 Global Oncology Biosimilars Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Oncology Biosimilars Sales Volume, Revenue and Growth Rate of G-CSF (2017-2022)
5.4.2 Global Oncology Biosimilars Sales Volume, Revenue and Growth Rate of Hematopoietic Agents (2017-2022)
5.4.3 Global Oncology Biosimilars Sales Volume, Revenue and Growth Rate of Monoclonal Antibodies (2017-2022)
6 GLOBAL ONCOLOGY BIOSIMILARS MARKET ANALYSIS BY APPLICATION
6.1 Global Oncology Biosimilars Consumption and Market Share by Application (2017-2022)
6.2 Global Oncology Biosimilars Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Oncology Biosimilars Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Oncology Biosimilars Consumption and Growth Rate of Retail pharmacies (2017-2022)
6.3.2 Global Oncology Biosimilars Consumption and Growth Rate of Hospital pharmacies (2017-2022)
6.3.3 Global Oncology Biosimilars Consumption and Growth Rate of Online pharmacies (2017-2022)
7 GLOBAL ONCOLOGY BIOSIMILARS MARKET FORECAST (2022-2027)
7.1 Global Oncology Biosimilars Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Oncology Biosimilars Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Oncology Biosimilars Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Oncology Biosimilars Price and Trend Forecast (2022-2027)
7.2 Global Oncology Biosimilars Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Oncology Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Oncology Biosimilars Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Oncology Biosimilars Revenue and Growth Rate of G-CSF (2022-2027)
7.3.2 Global Oncology Biosimilars Revenue and Growth Rate of Hematopoietic Agents (2022-2027)
7.3.3 Global Oncology Biosimilars Revenue and Growth Rate of Monoclonal Antibodies (2022-2027)
7.4 Global Oncology Biosimilars Consumption Forecast by Application (2022-2027)
7.4.1 Global Oncology Biosimilars Consumption Value and Growth Rate of Retail pharmacies(2022-2027)
7.4.2 Global Oncology Biosimilars Consumption Value and Growth Rate of Hospital pharmacies(2022-2027)
7.4.3 Global Oncology Biosimilars Consumption Value and Growth Rate of Online pharmacies(2022-2027)
7.5 Oncology Biosimilars Market Forecast Under COVID-19
8 ONCOLOGY BIOSIMILARS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Oncology Biosimilars Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Oncology Biosimilars Analysis
8.6 Major Downstream Buyers of Oncology Biosimilars Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Oncology Biosimilars Industry
9 PLAYERS PROFILES
9.1 Mylan
9.1.1 Mylan Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Oncology Biosimilars Product Profiles, Application and Specification
9.1.3 Mylan Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Celltrion Inc.
9.2.1 Celltrion Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Oncology Biosimilars Product Profiles, Application and Specification
9.2.3 Celltrion Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Dr. Reddy's Laboratories
9.3.1 Dr. Reddy's Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Oncology Biosimilars Product Profiles, Application and Specification
9.3.3 Dr. Reddy's Laboratories Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Pfizer Inc.
9.4.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Oncology Biosimilars Product Profiles, Application and Specification
9.4.3 Pfizer Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 STADA Arzneimittel AG
9.5.1 STADA Arzneimittel AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Oncology Biosimilars Product Profiles, Application and Specification
9.5.3 STADA Arzneimittel AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 F Hoffmann-La Roche
9.6.1 F Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Oncology Biosimilars Product Profiles, Application and Specification
9.6.3 F Hoffmann-La Roche Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 BIOCAD
9.7.1 BIOCAD Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Oncology Biosimilars Product Profiles, Application and Specification
9.7.3 BIOCAD Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Sandoz International GmbH
9.8.1 Sandoz International GmbH Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Oncology Biosimilars Product Profiles, Application and Specification
9.8.3 Sandoz International GmbH Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Biocon
9.9.1 Biocon Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Oncology Biosimilars Product Profiles, Application and Specification
9.9.3 Biocon Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Apotex Inc.
9.10.1 Apotex Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Oncology Biosimilars Product Profiles, Application and Specification
9.10.3 Apotex Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Teva Pharmaceutical Industries Ltd.
9.11.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Oncology Biosimilars Product Profiles, Application and Specification
9.11.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Intas Pharmaceuticals Ltd.
9.12.1 Intas Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Oncology Biosimilars Product Profiles, Application and Specification
9.12.3 Intas Pharmaceuticals Ltd. Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Oncology Biosimilars Product Picture
Table Global Oncology Biosimilars Market Sales Volume and CAGR (%) Comparison by Type
Table Oncology Biosimilars Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Oncology Biosimilars Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Oncology Biosimilars Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Oncology Biosimilars Industry Development
Table Global Oncology Biosimilars Sales Volume by Player (2017-2022)
Table Global Oncology Biosimilars Sales Volume Share by Player (2017-2022)
Figure Global Oncology Biosimilars Sales Volume Share by Player in 2021
Table Oncology Biosimilars Revenue (Million USD) by Player (2017-2022)
Table Oncology Biosimilars Revenue Market Share by Player (2017-2022)
Table Oncology Biosimilars Price by Player (2017-2022)
Table Oncology Biosimilars Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology Biosimilars Sales Volume, Region Wise (2017-2022)
Table Global Oncology Biosimilars Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology Biosimilars Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology Biosimilars Sales Volume Market Share, Region Wise in 2021
Table Global Oncology Biosimilars Revenue (Million USD), Region Wise (2017-2022)
Table Global Oncology Biosimilars Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share, Region Wise in 2021
Table Global Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Oncology Biosimilars Sales Volume by Type (2017-2022)
Table Global Oncology Biosimilars Sales Volume Market Share by Type (2017-2022)
Figure Global Oncology Biosimilars Sales Volume Market Share by Type in 2021
Table Global Oncology Biosimilars Revenue (Million USD) by Type (2017-2022)
Table Global Oncology Biosimilars Revenue Market Share by Type (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share by Type in 2021
Table Oncology Biosimilars Price by Type (2017-2022)
Figure Global Oncology Biosimilars Sales Volume and Growth Rate of G-CSF (2017-2022)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of G-CSF (2017-2022)
Figure Global Oncology Biosimilars Sales Volume and Growth Rate of Hematopoietic Agents (2017-2022)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Hematopoietic Agents (2017-2022)
Figure Global Oncology Biosimilars Sales Volume and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2017-2022)
Table Global Oncology Biosimilars Consumption by Application (2017-2022)
Table Global Oncology Biosimilars Consumption Market Share by Application (2017-2022)
Table Global Oncology Biosimilars Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Oncology Biosimilars Consumption Revenue Market Share by Application (2017-2022)
Table Global Oncology Biosimilars Consumption and Growth Rate of Retail pharmacies (2017-2022)
Table Global Oncology Biosimilars Consumption and Growth Rate of Hospital pharmacies (2017-2022)
Table Global Oncology Biosimilars Consumption and Growth Rate of Online pharmacies (2017-2022)
Figure Global Oncology Biosimilars Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Oncology Biosimilars Price and Trend Forecast (2022-2027)
Figure USA Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Oncology Biosimilars Market Sales Volume Forecast, by Type
Table Global Oncology Biosimilars Sales Volume Market Share Forecast, by Type
Table Global Oncology Biosimilars Market Revenue (Million USD) Forecast, by Type
Table Global Oncology Biosimilars Revenue Market Share Forecast, by Type
Table Global Oncology Biosimilars Price Forecast, by Type
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of G-CSF (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of G-CSF (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Hematopoietic Agents (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Hematopoietic Agents (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Table Global Oncology Biosimilars Market Consumption Forecast, by Application
Table Global Oncology Biosimilars Consumption Market Share Forecast, by Application
Table Global Oncology Biosimilars Market Revenue (Million USD) Forecast, by Application
Table Global Oncology Biosimilars Revenue Market Share Forecast, by Application
Figure Global Oncology Biosimilars Consumption Value (Million USD) and Growth Rate of Retail pharmacies (2022-2027)
Figure Global Oncology Biosimilars Consumption Value (Million USD) and Growth Rate of Hospital pharmacies (2022-2027)
Figure Global Oncology Biosimilars Consumption Value (Million USD) and Growth Rate of Online pharmacies (2022-2027)
Figure Oncology Biosimilars Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Mylan Profile
Table Mylan Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mylan Oncology Biosimilars Sales Volume and Growth Rate
Figure Mylan Revenue (Million USD) Market Share 2017-2022
Table Celltrion Inc. Profile
Table Celltrion Inc. Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celltrion Inc. Oncology Biosimilars Sales Volume and Growth Rate
Figure Celltrion Inc. Revenue (Million USD) Market Share 2017-2022
Table Dr. Reddy's Laboratories Profile
Table Dr. Reddy's Laboratories Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dr. Reddy's Laboratories Oncology Biosimilars Sales Volume and Growth Rate
Figure Dr. Reddy's Laboratories Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Oncology Biosimilars Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table STADA Arzneimittel AG Profile
Table STADA Arzneimittel AG Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales Volume and Growth Rate
Figure STADA Arzneimittel AG Revenue (Million USD) Market Share 2017-2022
Table F Hoffmann-La Roche Profile
Table F Hoffmann-La Roche Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F Hoffmann-La Roche Oncology Biosimilars Sales Volume and Growth Rate
Figure F Hoffmann-La Roche Revenue (Million USD) Market Share 2017-2022
Table BIOCAD Profile
Table BIOCAD Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BIOCAD Oncology Biosimilars Sales Volume and Growth Rate
Figure BIOCAD Revenue (Million USD) Market Share 2017-2022
Table Sandoz International GmbH Profile
Table Sandoz International GmbH Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz International GmbH Oncology Biosimilars Sales Volume and Growth Rate
Figure Sandoz International GmbH Revenue (Million USD) Market Share 2017-2022
Table Biocon Profile
Table Biocon Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biocon Oncology Biosimilars Sales Volume and Growth Rate
Figure Biocon Revenue (Million USD) Market Share 2017-2022
Table Apotex Inc. Profile
Table Apotex Inc. Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Apotex Inc. Oncology Biosimilars Sales Volume and Growth Rate
Figure Apotex Inc. Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table Intas Pharmaceuticals Ltd. Profile
Table Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales Volume and Growth Rate
Figure Intas Pharmaceuticals Ltd. Revenue (Million USD) Market Share 2017-2022
Figure Oncology Biosimilars Product Picture
Table Global Oncology Biosimilars Market Sales Volume and CAGR (%) Comparison by Type
Table Oncology Biosimilars Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Oncology Biosimilars Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Oncology Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Oncology Biosimilars Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Oncology Biosimilars Industry Development
Table Global Oncology Biosimilars Sales Volume by Player (2017-2022)
Table Global Oncology Biosimilars Sales Volume Share by Player (2017-2022)
Figure Global Oncology Biosimilars Sales Volume Share by Player in 2021
Table Oncology Biosimilars Revenue (Million USD) by Player (2017-2022)
Table Oncology Biosimilars Revenue Market Share by Player (2017-2022)
Table Oncology Biosimilars Price by Player (2017-2022)
Table Oncology Biosimilars Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology Biosimilars Sales Volume, Region Wise (2017-2022)
Table Global Oncology Biosimilars Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology Biosimilars Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology Biosimilars Sales Volume Market Share, Region Wise in 2021
Table Global Oncology Biosimilars Revenue (Million USD), Region Wise (2017-2022)
Table Global Oncology Biosimilars Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share, Region Wise in 2021
Table Global Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Oncology Biosimilars Sales Volume by Type (2017-2022)
Table Global Oncology Biosimilars Sales Volume Market Share by Type (2017-2022)
Figure Global Oncology Biosimilars Sales Volume Market Share by Type in 2021
Table Global Oncology Biosimilars Revenue (Million USD) by Type (2017-2022)
Table Global Oncology Biosimilars Revenue Market Share by Type (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share by Type in 2021
Table Oncology Biosimilars Price by Type (2017-2022)
Figure Global Oncology Biosimilars Sales Volume and Growth Rate of G-CSF (2017-2022)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of G-CSF (2017-2022)
Figure Global Oncology Biosimilars Sales Volume and Growth Rate of Hematopoietic Agents (2017-2022)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Hematopoietic Agents (2017-2022)
Figure Global Oncology Biosimilars Sales Volume and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2017-2022)
Table Global Oncology Biosimilars Consumption by Application (2017-2022)
Table Global Oncology Biosimilars Consumption Market Share by Application (2017-2022)
Table Global Oncology Biosimilars Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Oncology Biosimilars Consumption Revenue Market Share by Application (2017-2022)
Table Global Oncology Biosimilars Consumption and Growth Rate of Retail pharmacies (2017-2022)
Table Global Oncology Biosimilars Consumption and Growth Rate of Hospital pharmacies (2017-2022)
Table Global Oncology Biosimilars Consumption and Growth Rate of Online pharmacies (2017-2022)
Figure Global Oncology Biosimilars Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Oncology Biosimilars Price and Trend Forecast (2022-2027)
Figure USA Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Oncology Biosimilars Market Sales Volume Forecast, by Type
Table Global Oncology Biosimilars Sales Volume Market Share Forecast, by Type
Table Global Oncology Biosimilars Market Revenue (Million USD) Forecast, by Type
Table Global Oncology Biosimilars Revenue Market Share Forecast, by Type
Table Global Oncology Biosimilars Price Forecast, by Type
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of G-CSF (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of G-CSF (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Hematopoietic Agents (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Hematopoietic Agents (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Table Global Oncology Biosimilars Market Consumption Forecast, by Application
Table Global Oncology Biosimilars Consumption Market Share Forecast, by Application
Table Global Oncology Biosimilars Market Revenue (Million USD) Forecast, by Application
Table Global Oncology Biosimilars Revenue Market Share Forecast, by Application
Figure Global Oncology Biosimilars Consumption Value (Million USD) and Growth Rate of Retail pharmacies (2022-2027)
Figure Global Oncology Biosimilars Consumption Value (Million USD) and Growth Rate of Hospital pharmacies (2022-2027)
Figure Global Oncology Biosimilars Consumption Value (Million USD) and Growth Rate of Online pharmacies (2022-2027)
Figure Oncology Biosimilars Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Mylan Profile
Table Mylan Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mylan Oncology Biosimilars Sales Volume and Growth Rate
Figure Mylan Revenue (Million USD) Market Share 2017-2022
Table Celltrion Inc. Profile
Table Celltrion Inc. Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celltrion Inc. Oncology Biosimilars Sales Volume and Growth Rate
Figure Celltrion Inc. Revenue (Million USD) Market Share 2017-2022
Table Dr. Reddy's Laboratories Profile
Table Dr. Reddy's Laboratories Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dr. Reddy's Laboratories Oncology Biosimilars Sales Volume and Growth Rate
Figure Dr. Reddy's Laboratories Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Oncology Biosimilars Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table STADA Arzneimittel AG Profile
Table STADA Arzneimittel AG Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales Volume and Growth Rate
Figure STADA Arzneimittel AG Revenue (Million USD) Market Share 2017-2022
Table F Hoffmann-La Roche Profile
Table F Hoffmann-La Roche Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F Hoffmann-La Roche Oncology Biosimilars Sales Volume and Growth Rate
Figure F Hoffmann-La Roche Revenue (Million USD) Market Share 2017-2022
Table BIOCAD Profile
Table BIOCAD Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BIOCAD Oncology Biosimilars Sales Volume and Growth Rate
Figure BIOCAD Revenue (Million USD) Market Share 2017-2022
Table Sandoz International GmbH Profile
Table Sandoz International GmbH Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz International GmbH Oncology Biosimilars Sales Volume and Growth Rate
Figure Sandoz International GmbH Revenue (Million USD) Market Share 2017-2022
Table Biocon Profile
Table Biocon Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biocon Oncology Biosimilars Sales Volume and Growth Rate
Figure Biocon Revenue (Million USD) Market Share 2017-2022
Table Apotex Inc. Profile
Table Apotex Inc. Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Apotex Inc. Oncology Biosimilars Sales Volume and Growth Rate
Figure Apotex Inc. Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table Intas Pharmaceuticals Ltd. Profile
Table Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales Volume and Growth Rate
Figure Intas Pharmaceuticals Ltd. Revenue (Million USD) Market Share 2017-2022
